Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 157 of 157 entries
View as:

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06137586 Org: User:
Start: 08/10/22 End: 05/17/24 Due: 05/17/25

Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation

Phase: N/A Priority: Normal
NCT ID: NCT01513655 Org: User:
Start: 07/31/13 End: 07/31/20 Due: 07/31/21

The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06881459 Org: User:
Start: 03/25/25 End: 06/30/25 Due: 06/30/26

Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response

Phase: N/A Priority: Normal
NCT ID: NCT01534442 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04228484 Org: User:
Start: 01/07/20 End: 10/01/22 Due: 10/01/23

Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125

Phase: N/A Priority: Normal
NCT ID: NCT01436734 Org: User:
Start: 07/31/11 End: 05/31/13 Due: 05/31/14

Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

Phase: N/A Priority: Normal
NCT ID: NCT03013296 Org: User:
Start: 10/31/16 End: 09/30/18 Due: 09/30/19